SVRA - Savara Inc.
NEXT EARNINGS:
Mar 26, 2026
(in 29 days)
EPS Est: $-0.12
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$10.50
DETAILS
HIGH:
$11.00
LOW:
$10.00
MEDIAN:
$10.50
CONSENSUS:
$10.50
UPSIDE:
86.17%
Market Cap:
1.15B
Volume:
1,751,299
Avg Volume:
2,456,191
52 Week Range:
1.89-7.005
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.32
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
59
IPO Date:
2017-04-28
EPS (TTM):
-0.48
P/E Ratio:
-6.35
Revenue (TTM):
N/A
Total Assets:
212.88M
Total Debt:
26.73M
Cash & Equiv:
15.13M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-51.7%
Debt/Equity:
0.16
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.14 | $-0.13 | -7.7% | — | — | — |
| 2025-08-13 | $-0.14 | $-0.12 | -16.7% | — | — | — |
| 2025-05-13 | $-0.12 | $-0.12 | 0.0% | — | — | — |
| 2025-03-27 | $-0.13 | $-0.11 | -18.2% | $272000 | — | — |
| 2024-11-12 | $-0.11 | $-0.11 | 0.0% | — | — | — |
| 2024-08-12 | $-0.12 | $-0.11 | -9.1% | — | — | — |
| 2024-05-09 | $-0.11 | $-0.10 | -10.0% | — | — | — |
| 2024-03-07 | $-0.09 | $-0.11 | +18.2% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 257,000 | 0 | 0 | 0 | 400,000 | 54 | 1,548 | 0 |
| Net Income | (95.88M) | (54.70M) | (38.15M) | (43.01M) | (49.62M) | (78.17M) | (61.52M) | (29.80M) | (10.92M) | (39.84M) | (28.70M) | (21.48M) |
| EPS | -0.48 | -0.33 | -0.25 | -0.32 | -0.84 | -2.62 | -1.85 | -1.70 | -3.27 | -17.19 | -16.41 | -19.63 |
| Total Assets | 212.88M | 177.56M | 139.78M | 176.60M | 97.75M | 136.20M | 152.29M | 159.63M | 28.93M | 54.22M | 70.50M | 55.25M |
| Total Debt | 26.73M | 26.49M | 26.14M | 25.79M | 25.28M | 25.55M | 24.57M | 15.34M | 4.47M | 14.74M | 0 | 0 |
| Cash & Equivalents | 15.13M | 26.59M | 52.10M | 34.01M | 22.88M | 49.80M | 24.30M | 22.12M | 13.37M | 23.05M | 35.81M | 25.68M |
| Operating Cash Flow | (89.09M) | (51.06M) | (34.55M) | (40.08M) | (39.84M) | (45.12M) | (39.27M) | (28.23M) | (8.37M) | (32.95M) | (24.64M) | (17.79M) |
| Free Cash Flow | (89.11M) | (51.36M) | (34.56M) | (40.14M) | (43.13M) | (45.27M) | (39.42M) | (28.73M) | (8.38M) | (33.11M) | (24.79M) | (17.84M) |
| FCF per Share | -0.45 | -0.31 | -0.23 | -0.30 | -0.73 | -1.13 | -1.18 | -1.64 | -2.50 | -14.29 | -14.18 | -16.30 |
| Book Value | 171.45M | 140.37M | 107.78M | 144.50M | 64.38M | 101.70M | 108.22M | 119.31M | (35.88M) | 23.89M | 58.66M | 47.81M |
| Cash & ST Investments | 196.33M | 162.32M | 125.88M | 161.17M | 82.19M | 121.76M | 110.83M | 94.31M | 13.37M | 40.98M | 57.29M | 44.39M |
| ROC Equity | -0.56 | -0.39 | -0.35 | -0.30 | -0.77 | -0.77 | -0.57 | -0.25 | N/A | -1.67 | -0.49 | -0.45 |